BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK. Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease. Curr Neuropharmacol 2020;18:883-903. [PMID: 32348223 DOI: 10.2174/1570159X18666200429011823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kozin SA. Role of Interaction between Zinc and Amyloid Beta in Pathogenesis of Alzheimer’s Disease. Biochemistry Moscow 2023;88:S75-S87. [DOI: 10.1134/s0006297923140055] [Reference Citation Analysis]
2 Sincihu Y, Lusno MFD, Mulyasari TM, Elias SM, Sudiana IK, Kusumastuti K, Sulistyorini L, Keman S. Wistar Rats Hippocampal Neurons Response to Blood Low-Density Polyethylene Microplastics: A Pathway Analysis of SOD, CAT, MDA, 8-OHdG Expression in Hippocampal Neurons and Blood Serum Aβ42 Levels. Neuropsychiatr Dis Treat 2023;19:73-83. [PMID: 36636141 DOI: 10.2147/NDT.S396556] [Reference Citation Analysis]
3 Li Z, Ma H, Wang M, Qian Y. Research trend of microbiota-gut-brain axis in Alzheimer’s disease based on CiteSpace (2012–2021): A bibliometrics analysis of 608 articles. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1036120] [Reference Citation Analysis]
4 Akhgarjand C, Vahabi Z, Shab-bidar S, Etesam F, Djafarian K. Effects of probiotic supplements on cognition, anxiety, and physical activity in subjects with mild and moderate Alzheimer’s disease: A randomized, double-blind, and placebo-controlled study. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1032494] [Reference Citation Analysis]
5 Ghosh S, Sachdeva B, Sachdeva P, Chaudhary V, Rani GM, Sinha JK. Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease. Carbon Lett 2022. [DOI: 10.1007/s42823-022-00397-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Lamsal Lamichhane S, Ramesh V, Opara CO, Khan FY, Kabiraj G, Kauser H, Palakeel JJ, Ali M, Chaduvula P, Chhabra S, Mohammed L. Treatment Modalities for Dementia in Down’s Syndrome: A Literature Review. Cureus 2022. [DOI: 10.7759/cureus.27881] [Reference Citation Analysis]
7 Sood A, Goyal R, Singh H, Behl T, Arora S, Saini B, Kaur R. Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease. CNS Neurol Disord Drug Targets 2022;21:235-45. [PMID: 34414876 DOI: 10.2174/1871527320666210820092817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ghosh S, Sinha JK, Khan T, Devaraju KS, Singh P, Vaibhav K, Gaur P. Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy. Biomedicines 2021;9:470. [PMID: 33923061 DOI: 10.3390/biomedicines9050470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]